abstract |
Present invention relates to a topical pharmaceutical composition of apremilast or its pharmaceutical acceptable salts in range of 0.01 to 25% w/w, isopropyl myristate and optionally with one or more pharmaceutically acceptable excipients and process for the preparation thereof. Further, topical formulations of this invention are therefore suitable for the treatment of psoriasis and psoriatic arthritis and they may also be used with some other medicaments. |